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News and Views
Thrombosis Sewice in The Netherlands
In July l98l rhe Dutch Federation of Thrombosis'services held a congress on the
occasion of iu lOth anniversary. The congress was devoted to a discussion of the
.recenl .60 + trial' execured b1' Professor Loeliger and co.r'orkers frorn Leiden
University. This triat, the results of wich have been pubiished *'irh a discussion b1'
ProfcssoiMitcheil, has attracred a cenain amount of atrention [1.2]' It demonsttated
that constant deep anticoagulation afrer a first coronary inJarction can indeed
reduce the incidence of reinfarction. lr seems as if rhe man-v negative rrials reported
.did not obtain berter results because constart deep anticoaguladon could not be
guaranteed.
The thrombosis services aJe non-Profit organi'alions coveringg5fn of The Nether-
lands, where a team of nurses and a doctor supervise the anticoaguiant therapy of
patients referred to them b1' tbeir cardiologisa, other specialists or famill'doctors.
ir regular i-ntenrals the blood.level of ritarrinK dependent clotting factors is
ass..r.d, and a dose of orai alticoagulants prescribed. Parients unable to come lo
the ourpadent departtoent are venipunctured ar home. As up to 2c,o of the elderly
populaiion is on anticoagulant therapy, from one to several hundred padents are
*.n p.t day in each of the ?0 thrombo5is services in The Netheria-nds. Because the
ream of rhe rhrombosis service uniqueiy sDecieli'es il rhis task ord anricoagulation
can be given wirh substantiai intensiry and still the bleeding risk is smail (less than
oo. .rfO, bleeding per 2000 treatment ye:r's). The milor bleedings that occur ofren
appeaj ro have a diagnosric meaning as they may be early si*ens of. for example a
caicinoma. The Fedeiation of Tbrombosis Services has rhe task of coordinating the-.
different independelt services, as to price charged to the insurance companies,
qualiry of tbe laboratory esdmations, e!c-^ 
Constant deep'oral-anticoaguiation when properiy administered can reduce
reinfarcdon. This is of great practical importance, but ir also is not without
theoretical interest- Tbe common ideas about arterial a-nd venous thrombosis at tbe
moment cal be briefly summarized as follows. Venous *rrombosis is primariiy due
fo'$e clotting of Utooa; hence, oral anticoagulation will prevent it' Arterial
thrombosis is mediated by plateles, and hence antiplatelet therapy is the attack of
choicc. Recent research from tbe Maastricht (Limburg, The Netherlands) researeh
ft. Edt,- cn@uragcs rcadcrs to coon'butc to rhis scctiorr of thc Jouroal by scoding anicles 
of Do lDore
tlran 1000 *ords oo any ropic of irrerest-clinical scientific, cducational. poiidcal social 
or economic'
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group on thronbosis as presenred at a plenary lecture on tha r@ent International
Congrcs! on Thrombosis and Haemostasis in Toronto (Canada). gave good evidencc
that rhrombin at a @Dcenrrarion df 0.1% of thc thrombin potential in normal
plasm4 in cooperation with small a:nounts of collagen, isitbe most potent plarelet
activaror knowo. It may well be that the new adage should be: arterial thrornbosis is
mediared by plareleu; .since thrombin is the most potent platelet activator, anti-
coagulaat thcrapy is tbe best antiplatelet therapy..
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